These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36753000)

  • 1. Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease.
    Suwabe T; Ubara Y; Oba Y; Mizuno H; Ikuma D; Yamanouchi M; Sekine A; Tanaka K; Hasegawa E; Hoshino J; Sawa N
    J Nephrol; 2023 May; 36(4):999-1010. PubMed ID: 36753000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization.
    Suwabe T; Ubara Y; Mise K; Ueno T; Sumida K; Yamanouchi M; Hayami N; Hoshino J; Kawada M; Imafuku A; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K
    J Am Soc Nephrol; 2016 Jul; 27(7):2177-87. PubMed ID: 26620095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral nephrectomy versus renal arterial embolization and technique survival in peritoneal dialysis patients with autosomal dominant polycystic kidney disease.
    Pierre M; Moreau K; Braconnier A; Kanagaratnam L; Lessore De Sainte Foy C; Sigogne M; Béchade C; Petrache A; Verger C; Frimat L; Duval-Sabatier A; Caillard S; Halin P; Touam M; Issad B; Vrtovsnik F; Petitpierre F; Lobbedez T; Touré F
    Nephrol Dial Transplant; 2020 Feb; 35(2):320-327. PubMed ID: 31747008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-Threatening Retroperitoneal Hemorrhage Following Cyst Rupture in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Case Report.
    Duriseti P; Radhakrishnan Y; Chedid M; Hanna C; Potrezke TA; Chebib FT
    Am J Case Rep; 2023 Feb; 24():e938889. PubMed ID: 36843311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal transcatheter arterial embolization for autosomal dominant polycystic kidney disease: report of two cases.
    Masue N; Katoh S; Itoh S; Ehara H; Takahashi Y; Ishihara S; Deguchi T
    Hinyokika Kiyo; 2005 Nov; 51(11):741-5. PubMed ID: 16363706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive Refractory Renal Cyst Infection in Autosomal Dominant Polycystic Kidney Disease for which Renal Transcatheter Arterial Embolization Was Effective in Preventing Recurrence.
    Suwabe T; Oguro M; Ubara Y; Ikuma D; Mizuno H; Hayami N; Yamanouchi M; Sawa N
    Intern Med; 2021; 60(20):3261-3265. PubMed ID: 34657906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renal transcatheter arterial embolization on quality of life in patients with autosomal dominant polycystic kidney disease.
    Suwabe T; Ubara Y; Sekine A; Ueno T; Yamanouchi M; Hayami N; Hoshino J; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K
    Nephrol Dial Transplant; 2017 Jul; 32(7):1176-1183. PubMed ID: 28873973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial embolization of polycystic kidneys as an alternative to ergonomic nephrectomy in renal pre-transplantation. Monocentric retrospective study].
    Saljoghi R; Le Vourch A; Renard B; Villers A; Bouyé S
    Prog Urol; 2019 Sep; 29(10):482-489. PubMed ID: 31383509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation.
    Suwabe T; Ubara Y; Oba Y; Mizuno H; Ikuma D; Yamanouchi M; Sekine A; Tanaka K; Hasegawa E; Hoshino J; Sawa N
    Mayo Clin Proc Innov Qual Outcomes; 2023 Feb; 7(1):69-80. PubMed ID: 36712823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
    Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
    Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume regression of native polycystic kidneys after renal transplantation.
    Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
    Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume Reduction in Enlarged Kidneys in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Prior to Renal Transplant with Transcatheter Arterial Embolization (TAE): A Systematic Review and Meta-Analysis.
    Ye W; Voss MD; Athreya S
    Cardiovasc Intervent Radiol; 2018 Jun; 41(6):828-834. PubMed ID: 29388019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
    Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
    J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisterna chyli in autosomal dominant polycystic kidney disease.
    Thimmappa ND; Blumenfeld JD; Cerilles MA; Dunning A; Donahue SL; Bobb WO; Zhang HL; Prince MR
    J Magn Reson Imaging; 2015 Jan; 41(1):142-8. PubMed ID: 24470398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A; Lu Y; Kawano H; Horie S; Muto S
    Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
    Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
    Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study.
    Suwabe T; Ubara Y; Ueno T; Hayami N; Hoshino J; Imafuku A; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Saitoh S; Okuda I; Takaichi K
    BMC Nephrol; 2016 Nov; 17(1):170. PubMed ID: 27829402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.